Skip to main content
. 2016 Mar 25;60(4):2567–2571. doi: 10.1128/AAC.02536-15

TABLE 3.

Number of isolates with multidrug resistance, by serotypea

S. enterica serotype Total Pan-susceptible (%) MDR (%) MDR, ≥5 drugs (%) STR-SMX-TET (%) AMP-STR-SMX-TET (%) AMP-CHL-STR-SMX-TET (%)
All Salmonella 2,149 1,720 (80.0) 165 (7.7) 62 (2.9) 91 (4.2) 60 (2.8) 33 (1.5)
Enteritidis 284 263 (92.6) 9 (3.2) 4 (1.4) 5 (1.8) 5 (1.8) 3 (1.1)
Typhimurium 263 164 (62.4) 61 (23.2) 30 (11.4) 34 (12.9) 28 (10.6) 18 (6.8)
Newport 178 136 (76.4) 22 (12.4) 10 (5.6) 15 (8.4) 11 (6.2) 3 (1.7)
Heidelberg 149 84 (56.4) 22 (14.8) 2 (1.3) 14 (9.4) 1 (0.7) 0 (0)
Saintpaul 105 76 (72.4) 12 (11.4) 4 (3.8) 2 (1.9) 1 (1) 0 (0)
Other serotypes 1,069 920 (86.1) 23 (2.2) 6 (0.6) 13 (1.2) 6 (0.6) 4 (0.4)
Not serotyped 101 77 (76.2) 16 (15.8) 6 (5.9) 8 (7.9) 8 (7.9) 5 (5)
a

MDR, multidrug resistant; STR, streptomycin; SMX, sulfamethoxazole; TET, tetracycline; AMP, ampicillin; CHL, chloramphenicol.